drugset / Trial / NCT03980691

Effect of Chidamide Combined With CAT-T or TCR-T Cell Therapy on HIV-1 Latent Reservoir

NCT03980691

RandomizedParallel-groupOpen-labelTreatment

Summary

To study the safety and effectiveness of the combination of Chidamide with Chimeric Antigen Receptor(CAR)-T or T cell receptor(TCR)-T cell therapy on HIV patients based on cART.

Timeline

Start
2017-12-01
Primary completion
2020-05-31
Completion
2020-05-31

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Tucidinostat Small molecule